Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Erik Hulzebos

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Therapeutic Advances in Respiratory Disease|January 11, 2022
Physiological predictors of cardiorespiratory fitness in children and adolescents with cystic fibrosis without ventilatory limitationMarcella Burghard, Tim Takken, Merel M Nap-van der Vlist, et al.
Pediatric Pulmonology|April 2, 2020
Long-term effects of ivacaftor on nonpulmonary outcomes in individuals with cystic fibrosis, heterozygous for a S1251N mutationM Marcella Burghard, G Gitte Berkers, S Sophie Ghijsen, et al.
Chronic Respiratory Disease|September 6, 2022
The Exeter Activity Unlimited statement on physical activity and exercise for cystic fibrosis: methodology and results of an international, multidisciplinary, evidence-driven expert consensusCraig A Williams, Alan R Barker, Sarah Denford, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Therapeutic Advances in Respiratory Disease|January 11, 2022
Physiological predictors of cardiorespiratory fitness in children and adolescents with cystic fibrosis without ventilatory limitationMarcella Burghard, Tim Takken, Merel M Nap-van der Vlist, et al.
Pediatric Pulmonology|April 2, 2020
Long-term effects of ivacaftor on nonpulmonary outcomes in individuals with cystic fibrosis, heterozygous for a S1251N mutationM Marcella Burghard, G Gitte Berkers, S Sophie Ghijsen, et al.
Chronic Respiratory Disease|September 6, 2022
The Exeter Activity Unlimited statement on physical activity and exercise for cystic fibrosis: methodology and results of an international, multidisciplinary, evidence-driven expert consensusCraig A Williams, Alan R Barker, Sarah Denford, et al.
Pageof 2